National Cancer Institute
Found 428 results for your search:
Total relevant funding to Liver Cancer for this search:
$75,693,176
Fiscal Year FY 2016
Cancer Type [Liver Cancer]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 50 of 428 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
(PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer 1R01CA206465-01 $563,374 $563,374 JUSTICE, AMY YALE UNIVERSITY
2
(PQA4) Point-of-Care Test of Exposure to Hepatocellular Carcinoma Risk by V-Chip 4R01CA180083-04 $505,194 $505,194 QIN, LIDONG METHODIST HOSPITAL RESEARCH INSTITUTE
3
15-PGDH in Cholangiocarcinogenesis 2R01CA102325-10A1 $344,269 $344,269 WU, TONG TULANE UNIVERSITY OF LOUISIANA
4
2D and 3D Contrast-enhanced Ultrasound Evaluation of HCC Chemoembolization 1R01CA194307-01A1 $619,717 $619,717 EISENBREY, JOHN THOMAS JEFFERSON UNIVERSITY
5
A Bayesian Framework for Inter-Modality Deformable Image Registration Evaluation 5K01CA181292-04 $119,534 $29,884 CASTILLO, RICHARD UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
6
A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis 5R01CA190776-02 $636,299 $636,299 EL-SERAG, HASHEM BAYLOR COLLEGE OF MEDICINE
7
A novel diagnostic biomarker for Hepatocellular Carcinoma(HCC) 5R44CA165314-03 $657,468 $657,468 LU, XUANYONG IMCARE BIOTECH
8
A Novel Oral Therapeutic for Hepatocellular Carcinoma (HCC) 1R43CA206683-01 $267,105 $267,105 GROSS, COLEMAN EIGER GROUP INTERNATIONAL, INC.
9
A scalable platform for target validation in GEMM models of gastrointestinal malignancies. 5R01CA195787-02 $648,617 $324,309 LOWE, SCOTT SLOAN-KETTERING INST CAN RESEARCH
10
AARP prospective study of diet and cancer ZIA CP010196-03152 $1,229,987 $61,499 Sinha, Rashmi DCEG (NCI)
11
Aberrantly secreted glycoproteins as markers of liver cancer 4U01CA168856-05 $289,144 $289,144 MEHTA, ANAND DREXEL UNIVERSITY
12
Abramson Cancer Center Support Grant 2P30CA016520-40 $7,975,543 $159,511 DANG, CHI UNIVERSITY OF PENNSYLVANIA
13
Abramson Cancer Center Support Grant 3P30CA016520-40S1 $31,250 $625 DANG, CHI UNIVERSITY OF PENNSYLVANIA
14
Abramson Cancer Center Support Grant 3P30CA016520-40S2 $499,967 $9,999 DANG, CHI UNIVERSITY OF PENNSYLVANIA
15
Abramson Cancer Center Support Grant 3P30CA016520-40S3 $200,000 $4,000 DANG, CHI UNIVERSITY OF PENNSYLVANIA
16
ACN16002-001-00000 INVESTIGATION OF THE RELATIONSHIP BETWEEN LIVER EPIGENOMIC PHENOTYPE AND SUSCEPTIBILITY TO NON ALCOHOLIC STEATOHEPATITIS IN THE GENETICALLY DIVERSE MOUSE POPULATION. ACN16002001 $80,000 $80,000 UNKNOWN, UNKNOWN FOOD & DRUG ADMINISTRATION
17
Adaptive resistance to HIF1a inhibition in hypoxia 1R01CA207377-01 $352,242 $116,240 QIAN, ZHENG DAVID OREGON HEALTH & SCIENCE UNIVERSITY
18
Advanced Development of TIES-Enhancing Access to Tissue for Cancer Research 4U24CA180921-04 $634,033 $126,807 JACOBSON, REBECCA UNIVERSITY OF PITTSBURGH AT PITTSBURGH
19
Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse 4R01CA161694-05 $292,725 $292,725 SELL, STEWART WADSWORTH CENTER
20
Alliance for Clinical Trials in Oncology Operations Center 3U10CA180821-03S1 $1,595,651 $79,783 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
21
Alliance for Clinical Trials in Oncology Operations Center 3U10CA180821-03S2 $550,000 $27,500 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
22
Alliance for Clinical Trials in Oncology Operations Center 3U10CA180821-03S3 $750,000 $37,500 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
23
Alliance for Clinical Trials in Oncology Operations Center 5U10CA180821-03 $9,068,022 $453,401 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
24
Alliance of Glycobiologists for Detection of Cancer 4U01CA168926-05 $505,313 $505,313 GOLDMAN, RADOSLAV GEORGETOWN UNIVERSITY
25
Altered Growth Factor Pathways in Biliary Cancer 4R01CA083650-14 $307,269 $307,269 SIRICA, ALPHONSE VIRGINIA COMMONWEALTH UNIVERSITY
26
An Orthotopic Murine Model of HCC: Immunotolerance and Prevention 5R01CA164335-06 $301,525 $301,525 STAVELEY-O'CARROLL, KEVIN UNIVERSITY OF MISSOURI-COLUMBIA
27
An Orthotopic Murine Model of HCC: Immunotolerance and Prevention 7R01CA164335-05 $197,336 $197,336 STAVELEY-O'CARROLL, KEVIN UNIVERSITY OF MISSOURI-COLUMBIA
28
Analysis of Racial Disparities in HCC by Systems Metabolomics 3U01CA185188-02S1 $193,780 $193,780 RESSOM, HABTOM GEORGETOWN UNIVERSITY
29
Analysis of Racial Disparities in HCC by Systems Metabolomics 5U01CA185188-02 $255,915 $255,915 RESSOM, HABTOM GEORGETOWN UNIVERSITY
30
Anatomic Pathology Residency Program ZIE BC 011384 $1,014,935 $10,149 Barr, Frederic CCR (NCI)
31
ATBC Study ZIA CP010195-03031 $1,193,520 $119,352 Albanes, Demetrius DCEG (NCI)
32
Autophagy, mTOR inhibitors and phenformin in hepatocellular carcinoma 5R21CA191814-02 $184,663 $184,663 MERCER, CAROL UNIVERSITY OF CINCINNATI
33
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research ZIG BC 010856 $14,732,997 $736,650 Custer, Mary CCR (NCI)
34
Baylor College of Medicine Cancer Center 3P30CA125123-10S1 $118,016 $5,901 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
35
Baylor College of Medicine Cancer Center 3P30CA125123-10S2 $170,897 $8,545 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
36
Baylor College of Medicine Cancer Center 3P30CA125123-10S3 $118,875 $5,944 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
37
Baylor College of Medicine Cancer Center 3P30CA125123-10S4 $499,947 $24,997 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
38
Baylor College of Medicine Cancer Center 3P30CA125123-10S5 $134,220 $6,711 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
39
Baylor College of Medicine Cancer Center 5P30CA125123-10 $3,253,119 $162,656 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
40
Beneficial effects of Honokiol against liver cancer 5R21CA185943-02 $179,403 $179,403 SAXENA, NEERAJ UNIVERSITY OF MARYLAND BALTIMORE
41
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins ZIA BC 010030 $791,464 $39,573 Ambudkar, Suresh CCR (NCI)
42
Biological roles and Mediator-dependent transcription mechanisms of RNA polymerase II(G) 1R01CA202245-01 $387,731 $387,731 ROEDER, ROBERT ROCKEFELLER UNIVERSITY
43
Building upon a tradition of excellence. The NCTN at Indiana University 5U10CA180795-03 $611,729 $12,235 MILLER, KATHY INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
44
Calcineurin-NFAT regulates endothelial activation in pre-metastatic sites 3R01CA118374-08S1 $52,451 $26,226 RYEOM, SANDRA UNIVERSITY OF PENNSYLVANIA
45
Calcineurin-NFAT regulates endothelial activation in pre-metastatic sites 5R01CA118374-08 $342,000 $171,000 RYEOM, SANDRA UNIVERSITY OF PENNSYLVANIA
46
Cancer Center Support (Core) Grant 3P30CA014051-45S1 $395,141 $7,903 JACKS, TYLER MASSACHUSETTS INSTITUTE OF TECHNOLOGY
47
Cancer Center Support (Core) Grant 3P30CA014051-45S2 $746,692 $14,934 JACKS, TYLER MASSACHUSETTS INSTITUTE OF TECHNOLOGY
48
Cancer Center Support (Core) Grant 5P30CA014051-45 $3,572,644 $71,453 JACKS, TYLER MASSACHUSETTS INSTITUTE OF TECHNOLOGY
49
Cancer Center Support (CORE) Grant 3P30CA016672-41S1 $120,000 $4,800 DEPINHO, RONALD UNIVERSITY OF TX MD ANDERSON CAN CTR
50
Cancer Center Support (CORE) Grant 3P30CA016672-41S2 $123,768 $4,951 DEPINHO, RONALD UNIVERSITY OF TX MD ANDERSON CAN CTR
Total relevant funding to Liver Cancer for this search: $75,693,176
Showing 1 - 50 of 428 results
Go to top